Stay updated on Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial

Sign up to get notified when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial record for ECHO-208 is available, including its study design, participant criteria, treatment arms, locations, outcome measures, and posted results. It also shows the study was terminated and includes a study protocol and statistical analysis plan.
    Difference
    78%
    Check dated 2026-11-07T14:57:59.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T15:49:32.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    An NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” across NIH content. The underlying study page remains a 403 error.
    Difference
    1%
    Check dated 2026-10-24T18:52:53.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision number changed from v3.7.1 to v3.7.2; the study record remains inaccessible on the 403 page.
    Difference
    0.2%
    Check dated 2026-10-17T20:43:33.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The revision identifier in the page footer updates from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T20:52:17.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previously visible study record content and signaling restricted access to the study information. A basic 403 header and navigation appear where study details used to be.
    Difference
    22%
    Check dated 2026-09-19T22:25:10.000Z thumbnail image

Stay in the know with updates to Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.